Guideline characteristic (n GI tools) | GI tool categories and types (n, %) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Patient | Clinician | Implementation | Evaluation | |||||||||||
Total | Information | Self-management | Guideline summary | Total | Guideline summary | Algorithm | Form or checklist | Total | Training material | Resources | Total | Audit tool | Measures | |
Overall | 113 | 92 (81.4) | 15 (13.3) | 6 (5.3) | 239 | 116 (48.5) | 92 (38.5) | 31 (13.0) | 66 | 37 (56.1) | 29 (43.9) | 46 | 30 (65.2) | 16 (34.8) |
Condition | ||||||||||||||
 Diabetes | 37 | 31 (83.8) | 3 (8.1) | 3 (8.1) | 64 | 35 (54.7) | 18 (28.1) | 11 (17.2) | 20 | 12 (60.0) | 8 (40.0) | 9 | 6 (66.7) | 3 (33.3) |
 Stroke | 26 | 23 (88.5) | 2 (7.7) | 1 (3.8) | 63 | 40 (63.5) | 13 (20.6) | 10 (15.9) | 8 | 3 (37.5) | 5 (62.5) | 3 | 3 (100.0) | 0 (0.0) |
 Heart failure | 15 | 9 (60.0) | 4 (26.7) | 2 (13.3) | 48 | 5 (10.4) | 43 (89.6) | 0 (0.0) | 14 | 8 (57.1) | 6 (42.9) | 11 | 7 (63.6) | 4 (36.4) |
 Asthma | 15 | 10 (66.7) | 5 (33.3) | 0 (0.0) | 30 | 22 (73.3) | 4 (13.3) | 4 (13.3) | 4 | 3 (75.0) | 1 (25.0) | 1 | 0 (0.0) | 1 (100.0) |
 Arthritis | 12 | 12 (100.0) | 0 (0.0) | 0 (0.0) | 13 | 5 (38.5) | 8 (61.5) | 0 (0.0) | 6 | 1 (16.7) | 5 (83.3) | 4 | 2 (50.0) | 2 (50.0) |
 Depression | 5 | 4 (80.0) | 1 (20.0) | 0 (0.0) | 20 | 9 (45.0) | 5 (25.0) | 6 (30.0) | 10 | 8 (80.0) | 2 (20.0) | 7 | 2 (28.6) | 5 (71.4) |
 Colorectal cancer | 3 | 3 (100.0) | 0 (0.0) | 0 (0.0) | 1 | 0 (0.0) | 1 (100.0) | 0 (0.0) | 4 | 2 (50.0) | 2 (50.0) | 11 | 10 (90.9) | 1 (9.1) |
COUNTRY | ||||||||||||||
 United States (199) | 62 | 43 (69.4) | 13 (21.0) | 6 (9.7) | 121 | 58 (47.9) | 48 (39.7) | 15 (12.4) | 16 | 15 (93.8) | 1 (6.3) | 0 | 0 (0.0) | 0 (0.0) |
 United Kingdom (151) | 28 | 26 (92.9) | 2 (7.1) | 0 (0.0) | 38 | 6 (15.8) | 32 (84.2) | 0 (0.0) | 41 | 15 (36.6) | 26 (63.4) | 44 | 28 (63.6) | 16 (36.4) |
 Canada (90) | 21 | 21 (100.0) | 0 (0.0) | 0 (0.0) | 60 | 43 (71.7) | 4 (6.7) | 13 (21.7) | 8 | 6 (75.0) | 2 (25.0) | 1 | 1 (100.0) | 0 (0.0) |
 Australia (11) | 1 | 1 (100.0) | 0 (0.0) | 0 (0.0) | 9 | 5 (55.6) | 2 (22.2) | 2 (22.2) | 0 | 0 (0.0) | 0 (0.0) | 1 | 1 (100.0) | 0 (0.0) |
 International (8) | 1 | 1 (100.0) | 0 (0.0) | 0 (0.0) | 7 | 3 (42.9) | 4 (57.1) | 0 (0.0) | 0 | 0 (0.0) | 0 (0.0) | 0 | 0 (0.0) | 0 (0.0) |
 Singapore (3) | 0 | 0 (0.0) | 0 (0.0) | 0 (0.0) | 2 | 1 (50.0) | 0 (0.0) | 1 (50.0) | 1 | 1 (100.0) | 0 (0.0) | 0 | 0 (0.0) | 0 (0.0) |
 Brazil (2) | 0 | 0 (0.0) | 0 (0.0) | 0 (0.0) | 2 | 0 (0.0) | 2 (100.0) | 0 (0.0) | 0 | 0 (0.0) | 0 (0.0) | 0 | 0 (0.0) | 0 (0.0) |
 Finland (0) | 0 | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 | 0 (0.0) | 0 (0.0) | 0 | 0 (0.0) | 0 (0.0) |
 Spain (0) | 0 | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 | 0 (0.0) | 0 (0.0) | 0 | 0 (0.0) | 0 (0.0) |
Organization | ||||||||||||||
 Government (166) | 39 | 35 (89.7) | 3 (7.7) | 1 (2.6) | 48 | 12 (25.0) | 32 (66.7) | 4 (8.3) | 40 | 14 (35.0) | 26 (65.0) | 39 | 25 (64.1) | 14 (35.9) |
 Professional society (135) | 23 | 15 (65.2) | 3 (13.0) | 5 (21.7) | 97 | 41 (42.3) | 48 (49.5) | 8 (8.2) | 13 | 11 (84.6) | 2 (15.4) | 2 | 1 (50.0) | 1 (50.0) |
 Disease foundation (66) | 18 | 18 (100.0) | 0 (0.0) | 0 (0.0) | 37 | 25 (67.6) | 3 (8.1) | 9 (24.3) | 4 | 3 (75.0) | 1 (25.0) | 4 | 3 (75.0) | 1 (25.0) |
 Academic institution (63) | 29 | 21 (72.4) | 8 (27.6) | 0 (0.0) | 31 | 21 (67.7) | 3 (9.7) | 7 (22.6) | 6 | 6 (100.0) | 0 (0.0) | 0 | 0 (0.0) | 0 (0.0) |
 Non-profit agency (33) | 4 | 3 (75.0) | 1 (25.0) | 0 (0.0) | 25 | 16 (64.0) | 6 (24.0) | 3 (12.0) | 3 | 3 (100.0) | 0 (0.0) | 1 | 1 (100.0) | 0 (0.0) |
 International group (1) | 0 | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 | 1 (100.0) | 0 (0.0) | 0 (0.0) | 0 | 0 (0.0) | 0 (0.0) | 0 | 0 (0.0) | 0 (0.0) |